ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
Case Medical Research
◽
10.31525/ct1-nct04215653
◽
2020
◽
Author(s):
Keyword(s):
Randomised Controlled Trial
◽
Controlled Trial
◽
Efficacy And Safety
◽
Phase 3
◽
Duodenal Ulcers
◽
Randomised Controlled
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.741267002.793590492
◽
2021
◽
Author(s):
Pedro Legua Leiva
Keyword(s):
Randomised Controlled Trial
◽
Controlled Trial
◽
Trichuris Trichiura
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
School Aged Children
◽
Pemba Island
◽
Parallel Group
◽
Randomised Controlled
Download Full-text
OP032 Efficacy and safety of oral tofacitinib as maintenance therapy in patients with moderate to severe ulcerative colitis: results from a phase 3 randomised controlled trial
Journal of Crohn s and Colitis
◽
10.1093/ecco-jcc/jjx002.031
◽
2017
◽
Vol 11
(suppl_1)
◽
pp. S19-S20
◽
Cited By ~ 4
Author(s):
W.J. Sandborn
◽
B.E. Sands
◽
S. Danese
◽
G.R. D'Haens
◽
S. Vermeire
◽
...
Keyword(s):
Ulcerative Colitis
◽
Randomised Controlled Trial
◽
Maintenance Therapy
◽
Controlled Trial
◽
Efficacy And Safety
◽
Phase 3
◽
Severe Ulcerative Colitis
◽
Randomised Controlled
Download Full-text
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
The Lancet Diabetes & Endocrinology
◽
10.1016/s2213-8587(17)30308-x
◽
2017
◽
Vol 5
(11)
◽
pp. 864-876
◽
Cited By ~ 139
Author(s):
Paresh Dandona
◽
Chantal Mathieu
◽
Moshe Phillip
◽
Lars Hansen
◽
Steven C Griffen
◽
...
Keyword(s):
Type 1 Diabetes
◽
Randomised Controlled Trial
◽
Controlled Trial
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
Randomised Controlled
Download Full-text
Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(21)00421-7
◽
2021
◽
Author(s):
Eveline Hürlimann
◽
Ladina Keller
◽
Chandni Patel
◽
Sophie Welsche
◽
Jan Hattendorf
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Controlled Trial
◽
Trichuris Trichiura
◽
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
School Aged Children
◽
Pemba Island
◽
Parallel Group
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726972508.793526277
◽
2016
◽
Author(s):
Toshihiro Horii
◽
Nirianne Palacpac
Keyword(s):
Randomised Controlled Trial
◽
Combination Treatment
◽
Controlled Trial
◽
Efficacy And Safety
◽
First Line
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial
The Lancet Global Health
◽
10.1016/s2214-109x(16)30236-4
◽
2017
◽
Vol 5
(1)
◽
pp. e60-e68
◽
Cited By ~ 9
Author(s):
Hypolite Muhindo Mavoko
◽
Carolyn Nabasumba
◽
Raquel Inocêncio da Luz
◽
Halidou Tinto
◽
Umberto D'Alessandro
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Combination Treatment
◽
Controlled Trial
◽
Efficacy And Safety
◽
First Line
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
The Lancet
◽
10.1016/s0140-6736(15)60721-8
◽
2015
◽
Vol 386
(9988)
◽
pp. 31-45
◽
Cited By ~ 576
Keyword(s):
Randomised Controlled Trial
◽
Booster Dose
◽
Malaria Vaccine
◽
Controlled Trial
◽
Infants And Children
◽
Efficacy And Safety
◽
Phase 3
◽
Randomised Controlled
◽
In Infants And Children
Download Full-text
Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial
The Lancet Diabetes & Endocrinology
◽
10.1016/s2213-8587(18)30036-6
◽
2018
◽
Vol 6
(5)
◽
pp. 382-391
◽
Cited By ~ 12
Author(s):
Sobha Sivaprasad
◽
Joana C Vasconcelos
◽
A Toby Prevost
◽
Helen Holmes
◽
Philip Hykin
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Clinical Efficacy
◽
Macular Oedema
◽
Dark Adaptation
◽
Controlled Trial
◽
Diabetic Macular Oedema
◽
Efficacy And Safety
◽
Phase 3
◽
Multicentre Phase
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1159779.621190
◽
2009
◽
Author(s):
Rene Rizzoli
Keyword(s):
Randomised Controlled Trial
◽
Vertebral Compression Fracture
◽
Controlled Trial
◽
Compression Fracture
◽
Surgical Care
◽
Balloon Kyphoplasty
◽
Efficacy And Safety
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1166102.628092
◽
2009
◽
Author(s):
Jim Orr
◽
Fadi Abu Shahin
Keyword(s):
Ovarian Cancer
◽
Randomised Controlled Trial
◽
Controlled Trial
◽
Advanced Ovarian Cancer
◽
Open Label
◽
Phase 3
◽
Dose Dense
◽
Randomised Controlled
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close